In a recent episode of the Health Horizons podcast, Digital Diagnostics’ Founder and Executive Chairman Michael D. Abramoff, MD, PhD, reflects on the 10-plus years he’s worked to drive the changes needed to make autonomous AI solutions, like LumineticsCore®, clinically, economically, and ethically viable. Beyond the path to FDA clearance, reimbursement, and questions of liability, he emphasizes what matters most: using AI to deliver meaningful outcomes for patients.
Policy in Motion: Adapting to Autonomous AI with Prof. Michael Abramoff